Microbiology of Facial Skin Infections-Strains, Susceptibility, and Therapeutic Consequences.


Journal

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
ISSN: 1531-5053
Titre abrégé: J Oral Maxillofac Surg
Pays: United States
ID NLM: 8206428

Informations de publication

Date de publication:
05 2023
Historique:
received: 17 09 2022
revised: 30 12 2022
accepted: 30 12 2022
medline: 5 5 2023
pubmed: 23 1 2023
entrez: 22 1 2023
Statut: ppublish

Résumé

Skin and soft tissue infections (SSTIs) are common conditions with severe and potentially life-threatening outcomes. However, the use of antibiotics to treat these infections is controversial. This study was to identify the microorganisms responsible for facial SSTIs, their antibiotic sensitivities, and the therapeutic outcomes of treatment. This was a retrospective, observational cohort study conducted at a single oral and maxillofacial plastic surgery department. The study sample included 103 patients with facial SSTIs (61 men, 42 women) with a mean age of 41.8 years (standard deviation ± 20.4). The predictor variables included patient characteristics, antibiotic use before the clinic visit, and the infection's site and origin. The primary outcome variable was the presence of antibiotic resistance in the bacterial strains isolated from the infections. The data were collected by reviewing the results of microbiological swabs and patient records obtained from patients with facial SSTIs. Categorical variables were described using absolute and relative frequencies, and continuous variables were described using mean and standard deviation. The association between antibiotic resistance and the predictor variables was analyzed using Pearson's χ The most common cause of SSTI was an infected epidermal cyst (60.1%). Of all the microorganisms identified, 80.6% were Gram-positive, and 55.8% showed antibiotic resistance against one or more of the evaluated antibiotics, including several backup antibiotics. There were no identified risk factors that significantly influenced the probability of resistance, and there were no adverse events observed. The results of this study suggest that surgery should be the primary approach for treating SSTIs, as antibiotic administration may not be effective due to the unknown susceptibility of the causative strains. Antibiotics should be reserved for severe cases and high-risk patients, and if deemed necessary for SSTI management, a broad-spectrum antibiotic should be administered to cover resistant organisms.

Sections du résumé

BACKGROUND
Skin and soft tissue infections (SSTIs) are common conditions with severe and potentially life-threatening outcomes. However, the use of antibiotics to treat these infections is controversial.
PURPOSE
This study was to identify the microorganisms responsible for facial SSTIs, their antibiotic sensitivities, and the therapeutic outcomes of treatment.
STUDY DESIGN, SETTING, AND SAMPLE
This was a retrospective, observational cohort study conducted at a single oral and maxillofacial plastic surgery department. The study sample included 103 patients with facial SSTIs (61 men, 42 women) with a mean age of 41.8 years (standard deviation ± 20.4).
PREDICTOR/EXPOSURE/INDEPENDENT VARIABLES
The predictor variables included patient characteristics, antibiotic use before the clinic visit, and the infection's site and origin.
MAIN OUTCOME VARIABLE(S)
The primary outcome variable was the presence of antibiotic resistance in the bacterial strains isolated from the infections.
METHODS
The data were collected by reviewing the results of microbiological swabs and patient records obtained from patients with facial SSTIs. Categorical variables were described using absolute and relative frequencies, and continuous variables were described using mean and standard deviation. The association between antibiotic resistance and the predictor variables was analyzed using Pearson's χ
RESULTS
The most common cause of SSTI was an infected epidermal cyst (60.1%). Of all the microorganisms identified, 80.6% were Gram-positive, and 55.8% showed antibiotic resistance against one or more of the evaluated antibiotics, including several backup antibiotics. There were no identified risk factors that significantly influenced the probability of resistance, and there were no adverse events observed.
CONCLUSION
The results of this study suggest that surgery should be the primary approach for treating SSTIs, as antibiotic administration may not be effective due to the unknown susceptibility of the causative strains. Antibiotics should be reserved for severe cases and high-risk patients, and if deemed necessary for SSTI management, a broad-spectrum antibiotic should be administered to cover resistant organisms.

Identifiants

pubmed: 36682386
pii: S0278-2391(22)01120-X
doi: 10.1016/j.joms.2022.12.021
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-647

Informations de copyright

Copyright © 2023 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Felix Benjamin Warwas (FB)

Resident, Universityclinic of Bonn, Department of Oral-, Cranio-Maxillo and Facial Plastic Surgery, Bonn, Germany. Electronic address: felix.warwas@ukbonn.de.

Anne Klausing (A)

Resident, Universityclinic of Bonn, Department of Oral-, Cranio-Maxillo and Facial Plastic Surgery, Bonn, Germany.

Katharina Nentwig-Tschürtz (K)

Resident, Universityclinic of Bonn, Department of Oral-, Cranio-Maxillo and Facial Plastic Surgery, Bonn, Germany.

Moritz Berger (M)

Statistician, University of Bonn, Faculty of Medicine, Department of Medical Biometry, Informatics and Epidemiology, Bonn, Germany.

Franz-Josef Kramer (FJ)

Head of department, Universityclinic of Bonn, Department of Oral-, Cranio-Maxillo and Facial Plastic Surgery, Bonn, Germany.

Nils Heim (N)

Attending surgeon, Universityclinic of Bonn, Department of Oral-, Cranio-Maxillo and Facial Plastic Surgery, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH